granisetron has been researched along with Carcinoma, Epidermoid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, M; Shikimori, M; Yamshita, Y | 1 |
| Hashimoto, K; Komatsu, H; Shikimori, M; Yamashita, Y | 1 |
| Enomoto, H; Furukawa, M; Ikema, Y; Kawai, S; Kohno, H; Kubota, A; Makino, Y; Matsuda, H; Tsukuda, M; Yago, T | 1 |
| Kaufman, MB | 1 |
| Mori, K; Suga, Y; Takahashi, T; Tominaga, K | 1 |
| Fujii, M; Kanke, M; Tomita, T | 1 |
| Fujii, M; Imanishi, Y; Kanke, M; Kanzaki, J; Ohno, Y; Tokumaru, Y; Tomita, T | 1 |
3 trial(s) available for granisetron and Carcinoma, Epidermoid
| Article | Year |
|---|---|
[Clinical trial of chemotherapy by superselective intra-arterial infusion of nedaplatin combined with radiotherapy for advanced oral cancer].
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Granisetron; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Middle Aged; Mouth Neoplasms; Organoplatinum Compounds; Stomatitis | 2005 |
[Comparison of granisetron alone and granisetron plus dexamethasone or hydroxyzine hydrochloride for the prevention of nausea and vomiting during chemotherapy including cisplatin].
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Fluorouracil; Granisetron; Head and Neck Neoplasms; Humans; Hydroxyzine; Male; Middle Aged; Nausea; Vomiting | 1995 |
[Low-dose CDDP and 5-FU for head and neck cancer patients].
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Granisetron; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Neoadjuvant Therapy; Vomiting, Anticipatory | 1999 |
4 other study(ies) available for granisetron and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Granisetron reduces clinical and histological response to intra-arterial neoadjuvant chemotherapy in oral squamous cell carcinoma.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chi-Square Distribution; Cisplatin; Cohort Studies; Doxorubicin; Drug Interactions; Female; Granisetron; Humans; Injections, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Peplomycin; Retrospective Studies | 2006 |
Adverse effects associated with dexamethasone, lorazepam, and granisetron.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Dexamethasone; Female; Flushing; Granisetron; Head and Neck Neoplasms; Humans; Hyperemia; Infusions, Intravenous; Lorazepam | 1994 |
[Antiemetic efficacy of granisetron in patients receiving 5-day continuous infusion of cisplatin].
Topics: Adenocarcinoma; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Granisetron; Humans; Indazoles; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Nausea; Vindesine; Vomiting | 1993 |
Manifest Anxiety Scale for evaluation of effects of granisetron in chemotherapy with CDDP and 5FU for head and neck cancer.
Topics: Adult; Aged; Antiemetics; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Evaluation Studies as Topic; Female; Fluorouracil; Granisetron; Head and Neck Neoplasms; Humans; Male; Manifest Anxiety Scale; Middle Aged; Nausea; Vomiting | 2001 |